Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Gynecologic Oncology|August 7, 2010
Periostin promotes ovarian cancer angiogenesis and metastasisMin Zhu, Marlena S Fejzo, Lee Anderson, et al.Hepatology (Baltimore, Md.)|January 10, 2013
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitroRichard S Finn, Alexey Aleshin, Judy Dering, et al.Neoplasia (New York, N.Y.)|August 7, 2010
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanomaWilliam D Tap, Ke-Wei Gong, Judy Dering, et al.Breast Cancer Research : BCR|October 31, 2009
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroRichard S Finn, Judy Dering, Dylan Conklin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancerDong-Joo Cheon, Yunguang Tong, Myung-Shin Sim, et al.Molecular Cancer Therapeutics|July 1, 2010
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell linesEdward B Garon, Richard S Finn, Wylie Hosmer, et al.Breast Cancer Research and Treatment|February 10, 2015
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of responseSara A Hurvitz, Ondrej Kalous, Dylan Conklin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2013
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancerEdward B Garon, Richard J Pietras, Richard S Finn, et al.Breast Cancer Research and Treatment|October 5, 2013
AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53Ondrej Kalous, Dylan Conklin, Amrita J Desai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancerAngelo Di Leo, Henry L Gomez, Zeba Aziz, et al.Pageof 3